Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease  James J. Schuler,

Published byRatna Setiawan Modified over 4 years ago

Similar presentations

Presentation on theme: "Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease  James J. Schuler,"— Presentation transcript:

1 Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease  James J. Schuler, M.D., D.Preston Flanigan, M.D., James W. Holcroft, M.D., Joseph J. Ursprung, Ph.D., J.Scott Mohrland, Ph.D., Judy Pyke, M.S.  Journal of Vascular Surgery  Volume 1, Issue 1, Pages (January 1984) DOI: / (84) Copyright © 1984 Mosby, Inc. Terms and Conditions

2 Fig. 1 Final result of PGE1 vs. placebo treatment showing percent of ulcers that healed completely, were reduced by 20% or more in surface area, remained unchanged or increased by 20% or more, developed during the course of treatment, and had inadequate follow-up. The differences between treated group and placebo were not significant. Journal of Vascular Surgery 1984 1, DOI: ( / (84) ) Copyright © 1984 Mosby, Inc. Terms and Conditions

3 Fig. 2 Percent of patients in two groups with at least one ulcer completely healed during course of study. Journal of Vascular Surgery 1984 1, DOI: ( / (84) ) Copyright © 1984 Mosby, Inc. Terms and Conditions

4 Fig. 3 Percent of patient in two groups who had a 20% or greater reduction in total ulcer surface area as compared with those that remained unchanged or increased by 20% or more following one infusion of PGE1 or placebo. Differences between two groups were not significant. Journal of Vascular Surgery 1984 1, DOI: ( / (84) ) Copyright © 1984 Mosby, Inc. Terms and Conditions

5 Fig. 4 Percent of patients in two groups who had a 20% greater reduction in total ulcer surface area as compared with those that remained unchanged or increased or increased by 20% or more at final follow-up visit 2 months after last infusion. Differences between two groups were not significant. Journal of Vascular Surgery 1984 1, DOI: ( / (84) ) Copyright © 1984 Mosby, Inc. Terms and Conditions

6 Fig. 5 Average of patients' subjective evaluation of degree of rest pain graded on a scale of 0 to 7 prior to beginning of treatment and at time of final follow-up 2 months after last infusion. These differences were not significant. Journal of Vascular Surgery 1984 1, DOI: ( / (84) ) Copyright © 1984 Mosby, Inc. Terms and Conditions

7 Fig. 6 Average of analgesic medication use required for relief of rest pain graded on a scale of 0 to 5 prior to beginning of treatment and at time of final follow-up 2 months after last infusion. These differences were not significant. Journal of Vascular Surgery 1984 1, DOI: ( / (84) ) Copyright © 1984 Mosby, Inc. Terms and Conditions

Download ppt "Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease  James J. Schuler,"

Similar presentations

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.
Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages 1072-1082 (October 2014) DOI:

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Evaluation and treatment of allergic fungal sinusitis. II

Evaluation and treatment of allergic fungal sinusitis. II
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.
Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 

Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 
Evaluation and treatment of allergic fungal sinusitis. II

Evaluation and treatment of allergic fungal sinusitis. II
A Phase II Pilot Study to Evaluate Use of Intravenous Lidocaine for Opioid-Refractory Pain in Cancer Patients  Shekhar Sharma, MS, M.R. Rajagopal, MD,

A Phase II Pilot Study to Evaluate Use of Intravenous Lidocaine for Opioid-Refractory Pain in Cancer Patients  Shekhar Sharma, MS, M.R. Rajagopal, MD,
One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease  Corey A. Kalbaugh, MS,

One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease  Corey A. Kalbaugh, MS,
The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation  Jeroen Otte, MD, MSc, Jaap J. van Netten,

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation  Jeroen Otte, MD, MSc, Jaap J. van Netten,
Defining successful mobility after lower extremity amputation for complications of peripheral vascular disease and diabetes  Daniel C. Norvell, PhD, Aaron.

Defining successful mobility after lower extremity amputation for complications of peripheral vascular disease and diabetes  Daniel C. Norvell, PhD, Aaron.
In search of optimal compression therapy for venous leg ulcers: A meta-analysis of studies comparing divers bandages with specifically designed stockings 

In search of optimal compression therapy for venous leg ulcers: A meta-analysis of studies comparing divers bandages with specifically designed stockings 
Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers  Eugenio Brizzio, MD, Felix Amsler, MS,

Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers  Eugenio Brizzio, MD, Felix Amsler, MS,
Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection  Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection  Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
NMDA-Receptor Antagonists in Neuropathic Pain

NMDA-Receptor Antagonists in Neuropathic Pain
Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers  Eugenio Brizzio, MD, Felix Amsler, MS,

Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers  Eugenio Brizzio, MD, Felix Amsler, MS,
Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain  Marianne Silver, MS, David Blum, MD,

Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain  Marianne Silver, MS, David Blum, MD,

Similar presentations

Ads by Google